> ## Content Index
> Fetch the complete content index at: https://www.medi-hi.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Graves' Disease: Why Ongoing Care Matters Even with Normal Thyroid Levels
- URL: https://www.medi-hi.com/en/info/graves-disease-autoimmune-thyroid-cause-en/
- Published: 2026-10-23T00:48:44.000Z
- Updated: 2026-10-23T01:34:26.000Z
- Author: medihi
- Tags: 갑상선, #info, #in_날라, #in_차차, #in_이희재, #in_의료진감수, #vitagenichkm, #lang-en

POINT 

## In This Article

Even if thyroid hormone levels return to the normal range, it may not mean Graves’ disease treatment is finished. Whether to continue treatment is determined by reviewing hormone levels along with antibody status and the possibility of relapse. Below is a consolidated guide to the key features of Graves’ disease, and how testing and treatment options are typically considered. 

## 1\. Are hyperthyroidism and Graves’ disease different?

![An illustration depicting hyperthyroidism symptoms and pathology](https://www.medi-hi.com/content/images/2026/10/graves-disease-autoimmune-thyroid-cause_02.gif)

Hyperthyroidism is a state in which the thyroid produces too much thyroid hormone, and Graves’ disease is one of the conditions that can cause it. In Graves’ disease, autoimmune antibodies continue to stimulate the thyroid gland.

Using a car analogy: hyperthyroidism is like driving at a high speed, while Graves’ disease is like an accelerator pedal that stays pressed down even when you’re not stepping on it. Even if medication lowers hormone levels, if the antibody-driven stimulation remains, hyperthyroidism can return after stopping treatment.

In other words, normal hormone levels do not necessarily mean the autoimmune activity has fully settled.

---

## 2\. Why do we check the TRAb test?

![An infographic showing clinical action steps based on TRAb antibody test results](https://www.medi-hi.com/content/images/2026/10/graves-disease-autoimmune-thyroid-cause_03.gif)

TRAb (TSH receptor antibody) is an indicator used to assess whether the autoimmune stimulation that drives the thyroid is still present. Even after hormone levels normalize, it can be referenced when deciding whether treatment should be continued.

However, TRAb alone cannot definitively predict relapse. Symptoms, hormone levels, treatment duration, and other factors should be reviewed together.

**✅How to interpret results in practice**

- If TRAb is high, you may discuss extending the medication period in consideration of relapse risk after stopping the drug.
- If TRAb decreases or normalizes and TSH and thyroid hormone levels are stable, you may discuss whether to stop antithyroid medication, taking into account symptoms, treatment duration, and relapse risk.
- The initial treatment approach is decided by considering age, thyroid size, eye involvement (ophthalmopathy), pregnancy plans, coexisting conditions, and patient preferences.

---

## 3\. How are Graves’ disease treatment options chosen?

Treatment options include antithyroid medication, radioactive iodine, and surgery. The choice is made by considering coexisting conditions, eye symptoms, pregnancy plans, medication side effects, and relapse. No single approach applies the same way to every patient.

Antithyroid medication controls thyroid function without destroying the gland, but treatment can be prolonged and relapse may occur after discontinuation. If there is no pregnancy plan and surgery feels burdensome, treatment often starts with medication.

Radioactive iodine is a treatment that destroys thyroid tissue, and thyroid function may decrease afterward. If there is active Graves’ ophthalmopathy or a higher risk of worsening eye symptoms, it should be chosen cautiously, considering the possibility that symptoms may become more severe after treatment.

After surgery, thyroid hormone replacement needs to be taken continuously. Rarely, complications such as hypoparathyroidism or nerve injury affecting vocal cord movement can occur. Surgery may be considered when the thyroid is very large or cancer is suspected. If there are severe medication side effects or repeated relapses, radioactive iodine or surgery may be reviewed as options.

---

## 4\. How is it different from Hashimoto’s thyroiditis?

![An illustration representing Hashimoto's thyroiditis and chronic thyroid inflammation](https://www.medi-hi.com/content/images/2026/10/graves-disease-autoimmune-thyroid-cause_05.gif)

Both conditions are related to autoimmunity, but they affect thyroid function differently. In Graves’ disease, antibodies stimulate the thyroid, leading it to produce more hormone.

In Hashimoto’s thyroiditis, autoimmune activity damages thyroid tissue, and over time thyroid function often declines. Early on, there may be a temporary release of excess hormone that can look like hyperthyroidism, but it tends to shift toward reduced function later.

If thyroid function is reduced, the treatment goal is to maintain metabolism by replacing the hormone that is lacking. Even among autoimmune thyroid diseases, management differs depending on the diagnosis. For that reason, it can be important to confirm which condition is present and to review how antibody test results and pregnancy plans may influence treatment direction.

---

## 5\. If my numbers improve, can I stop the medication?

Even if hormone levels are normal and symptoms are stable, autoimmune activity may still remain, so stopping medication on your own is not appropriate.

In Graves’ disease, a stable state of symptoms and lab values is called “remission.” This means the condition is currently stable, not that relapse can be ruled out. Ongoing monitoring may still be needed.

If remission is maintained, clinic visits may become less frequent and you may be able to do well without medication. On the other hand, depending on antibodies or symptoms, additional management may be necessary, so it’s best to coordinate the timing of discontinuation with your clinician.

If you have unexplained rapid weight loss, severe palpitations, or persistent hand tremor, your status should be checked. If you have severe chest pain, shortness of breath, fainting, eye pain, vision changes, double vision, or if you are planning pregnancy, it may be safer to move up the timing of your consultation.

---

## 6\. Frequently Asked Questions (FAQ)

#### Q. Are thyrotoxicosis and hyperthyroidism different?

Thyrotoxicosis refers to the overall state of having excessive thyroid hormone in the blood. Hyperthyroidism is when the thyroid gland itself is producing too much hormone, and Graves’ disease is one possible cause.

#### Q. If my levels are normal, why is it still called Graves’ disease?

TSH, T3, and T4 tests show current thyroid function. Graves’ disease is a condition in which TRAb antibodies stimulate the thyroid, so even when levels are stable, antibody status may still be reviewed.

#### Q. How long do I need to take Graves’ disease medication?

Antithyroid medication can be adjusted and reassessed over months to years. Decisions about stopping or continuing at a low dose are made by considering TRAb, relapse, coexisting conditions, and the feasibility of follow-up.

#### Q. What symptoms mean I should seek consultation sooner?

Unexplained rapid weight loss, severe palpitations, and persistent tremor should be checked. If you have severe chest pain, shortness of breath, fainting, eye pain, vision changes, double vision, or pregnancy plans, it may be safer to bring your consultation forward.

[ RECOMMENDED READ Thyroid Emergency Symptoms: Red Flags Needing Immediate Care Are your thyroid symptoms an emergency? Learn how to spot critical red flags like high fever, altered consciousness, and sudden paralysis for rapid care. ➔ ](https://www.medi-hi.com/en/info/thyroid-emergency-symptoms-warning-signs-en/) 

This health content has been reviewed by medical professionals, compiled from authoritative domestic and international sources, and is regularly updated in accordance with the latest clinical guidelines. 

Last Reviewed: Oct 23, 2026 Last Updated: Oct 23, 2026 

### Sources

- Endocrinology and Metabolism, Korea consensus report on hyperthyroidism management.
- Korea Disease Control and Prevention Agency (KDCA) National Health Information Portal, health information on hyperthyroidism and hypothyroidism.
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism.

※ The copyright for all content on this blog belongs to medihi. Unauthorized copying, distribution, or derivative use is strictly prohibited, and violations may result in legal action without prior notice.

### 

## 

##